Cuspal deflection and microleakage in premolar teeth restored with bulk-fill flowable resin-based composite base materials.

OBJECTIVES: To assess the cuspal deflection and cervical microleakage of standardised Class II cavities incrementally filled with a dimethacrylate RBC or bulk-fill flowable RBC bases. METHODS: Twenty-four sound upper premolar teeth with Class II cavities were allocated to three groups (n=8). Restoration of the teeth involved the placement of an RBC (GrandioSO) in eight oblique increments (Group A) or Groups B and C were restored to within 2 mm of the palatal cusp in a single increment with bulk-fill flowable RBC bases (SDR and x-tra base) before the two occlusal cavity increments were placed with GrandioSO. Buccal and palatal cusp deflections were recorded postirradiation using a twin channel deflection measuring gauge. Following restoration, the teeth were thermocycled, immersed in 0.2% basic fuchsin dye for 24h, sectioned and examined for cervical microleakage. RESULTS: The mean total cuspal deflection for the oblique incremental restoration technique was 11.26 (2.56) µm (Group A) and 4.63 (1.19) µm (Group B) and 4.73 (0.99) µm (Group C) for the bulk-fill flowable RBC bases. A significant increase in the mean total cuspal deflection for the incrementally filled GrandioSO compared with the SDR (P=0.007) and x-tra base (P=0.005) restored teeth was evident. No significant difference in the cervical microleakage scores was recorded between groups AC (P>0.05). CONCLUSIONS: The bulk-fill flowable RBC bases significantly reduced cuspal deflection compared with a conventional RBC restored in an oblique incremental filling technique with no associated change in cervical microleakage recorded.

Regression of early diabetic macular oedema is associated with prevention of dark adaptation.

HYPOTHESIS: Dark-adapted rods consume oxygen at high rates and light adaptation decreases this oxygen burden and can have therapeutic effects on diabetic macular oedema (DMO). METHODS: Patients with mild non-proliferative diabetic retinopathy (DR) and early, untreated non-sight-threatening DMO slept for 6 months wearing masks that illuminated the eyelid of one closed eye by 505 nm light. Exclusion criteria were any concomitant eye disease, DR >ETDRS grade 35, and other systemic diseases. PRIMARY OUTCOME: change of OCT retinal thickness in the local region where oedema was present. RESULTS: A total of 34 out of 40 patients completed the study. Mean baseline OCT macular cube thickness was equivalent for study and fellow eyes. But study eyes had a greater mean thickness in the central subfield zone 1 (282±53 µm) vs (256±19 µm) the fellow eyes. Twenty-eight study eyes showed intraretinal cysts compared with nine in the fellow eyes. At 6 months, only 19 study eyes had cysts while cysts were seen in 20 fellow eyes. After 6 months, the worst affected ETDRS zone and the central subfield zone 1 reduced in thickness in study eyes only by 12 µm (95% CI 20 to -7, P=0.01). The secondary outcomes of change in visual acuity, achromatic contrast sensitivity, and microperimetric thresholds improved significantly in study eyes and deteriorated in fellow eyes. CONCLUSIONS: Sleeping in dim light that can keep rods light adapted may reverse the changes of DMO.